neurosciences

>> PROJECT   |  JOIN US   |   LINKS   |  TEACHING

 

Treatments for Alzheimer’s and Parkinson’s disease

Scientists working in the Neurosciences Division study the genetic and molecular basis of neuronal death in Alzheimer’s and Parkinson´s disease including the cellular mechanisms involved in the origin of memory loss in these patients. They are also working to develop imaging, neurophysiological or biochemical methods for early diagnosis in people with mild cognitive disorder or Parkinson´s disease, which may lead to finding more effective treatments.

The laboratories devoted to Parkinson’s and Alzheimer´s disease explore new therapeutic approaches, including therapies that use adult stem cells and trophic factors to promote neuronal regeneration and differentiation and new pharmacological treatments. Other approaches as deep brain stimulation are also useful for parkinsonian patients who do not respond to other types of treatment.

Among the research centers outside Spain with which CIMA has agreements are the University College London, the University of Edinburgh and the Massachusetts General Hospital (associated with Harvard Medical School) in Boston.